A lung cancer drug developed by Akeso Inc. extended patients’ lives by about four months in a late-stage trial in China, results that will likely raise expectations for a closely watched new class of treatments.

The Taiwan president’s spokeswoman said China used “baseless pretexts” to punish journalists, which she called evidence that Beijing was a “troublemaker.”